News from the FDA/CDC
News from the FDA/CDC
FDA panel votes against 2 cancer indications but backs 4 of 6
At a 3-day meeting, an FDA advisory group considered the accelerated approvals of six cancer indications for three immunotherapies.
News
FDA moves to ban menthol in cigarettes
News
CDC guidelines coming on long COVID
News from the FDA/CDC
To stay: Two more cancer indications with ‘dangling approvals’
News from the FDA/CDC
FDA panel backs atezolizumab for mTNBC – at least for now
FDA advisers voted to keep in place an approval for atezolizumab in metastatic triple-negative breast cancer.
News from the FDA/CDC
Feds lift pause of J&J COVID vaccine, add new warning
The warning is directed at women under the age of 50.
News from the FDA/CDC
FDA approves new immunotherapy for endometrial cancer
The accelerated approval for dostarlimab is for use in patients with recurrent or advanced endometrial cancers with deficient mismatch repair.
News from the FDA/CDC
FDA approves frontline immunotherapy for gastric cancers
Nivolumab is now approved for the frontline treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal...
News from the FDA/CDC
CDC panel: Pause of J&J COVID-19 vaccine to remain for now
“Putting this vaccine on pause for those of us that are frontline health care workers has really been devastating.”
News from the FDA/CDC
FDA approves first AI device to detect colon lesions
The GI Genius works in conjunction with an endoscope during colonoscopy, highlighting possible polyps.
News
List of COVID-19 high-risk comorbidities expanded
Underlying conditions increase the risk of severe outcomes for patients infected with SARS-CoV-2.